NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Florida Health Care Associates is a professional corporation that engages medical providers who are duly licensed inFlorida to provide primary care and RPM services (http://www.floridahealthcareassociates.com/home.htm)
The NuGenHealth system offers direct savings to physicians and healthcare organizations both in time and money, allowing the healthcare team to monitor patient progress outside the practice office, leading to timely interventions and early identification of disease progression that may prevent unnecessary hospitalizations. The SaaS system utilizes automated algorithms, real-time data, and quality metrics to involve patients in their own care, while keeping healthcare providers and family constantly informed.
RPM is the use of digital technologies to monitor and capture medical/health data from patients and electronically transmit the information to their providers for assessment, recommendations, and instructions. Providers use RPM to collect a wide range of patient data, including blood pressure, weight, heart rate, and blood sugar levels.
Under the terms of the agreement, NuGenHealth will provide the SaaS system and implementation, personnel training, and system oversight to optimize workflows for RPM and to collect, analyze, and report real-time patient data. NuGenHealth will also supply FHCA with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population. In collaboration with and assistance from the NuGenHealth implementation team, FHCA will implement the NuGenHealth SaaS suite on site, handle the initial onboarding of patients, train their patients on the use of the monitoring devices, and manage the day-to-day monitoring of their RPM patient population.
About
Cautionary Note Regarding Forward-Looking Statements
This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the
Generex Contact:
646-599-6222
1-800-391-6755 Extension 222
investor@generex.com
2021 GlobeNewswire, Inc., source